DSGN Competitors & Alternatives

Compare Design Therapeutics Inc with similar stocks in the same industry

Biotechnology

DSGN

Main Stock
$9.94
-5.06%
Tradestie Score
49
Market Cap
$386.68M
Analyst Upside
+117.0%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 3/10 Drug Discovery Biotech Drug Design
Competitive Moat: None
Core Technology Stack: GeneTAC platform, gene-targeted chimeric small molecules
Major Customers 2
Patients with genetic disorders Clinical research sites
Critical Suppliers 2
Contract research organizations API manufacturers
Direct Ecosystem Rivals 3

Top Competitors

215 stocks in Biotechnology
Company Price Market Cap P/E Score Action
TBPH Theravance Biopharma, Inc.
$17.03
$726.21M 16.4 51 Compare
NRIX Nurix Therapeutics, Inc. Common stock
$15.01
-3.04%
$718.62M 6.4 52 Compare
TYRA Tyra Biosciences, Inc. Common Stock
$19.77
-1.27%
$715.25M - 31 Compare
DAWN Day One Biopharmaceuticals, Inc. Common Stock
$21.53
+0.19%
$704.73M - 51 Compare
PVLA Palvella Therapeutics, Inc. Common Stock
$145.03
-4.89%
$699.30M - 49 Compare
TERN Terns Pharmaceuticals, Inc. Common Stock
$52.95
+0.04%
$683.46M - 49 Compare
ANL ANL
$9.97
-6.03%
$677.47M - 48 Compare
MGTX MeiraGTx Holdings plc Ordinary Shares
$8.85
-3.59%
$665.30M 10.1 46 Compare
ERAS Erasca, Inc. Common Stock
$14.95
-4.57%
$626.91M - 35 Compare
SVRA Savara Inc.
$4.43
-4.63%
$611.84M - 56 Compare

Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2834)

215 stocks in this industry